Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

Monk44, IMO they would need to conduct a brand new clinical trial for that population of patients (many months). A study in India was just completed and they concluded the opposite of what NIH concluded. India now has approved EUA for Aviptadil. So outside of the USA there is progress with the drug. But let's face it, as a viable investment, we need the FDA blessing. Here is the link to that study in India. The results were GREAT !! So there is something fishy going on with that NIH trial. Conspiracy against therapeutics in favor of vaccines? Who knows for sure. We do know that Aviptadil was only administered for just 3 days, while Remdes was administered for 10 days. I'd like to know why the difference in protocol? 3 days doesn't seem very long to me for someone who is dying.

https://acrobat.adobe.com/link/review?uri=urn%3Aaaid%3Ascds%3AUS%3A91aa11ad-10cc-3179-8838-1a6d8b949439&fbclid=IwAR005OpIYAc0QcsmmB78gNm4EDk46WeImEX4sgtJ3xE5RUr4sSShD7ZiiJA&fs=e&s=cl#pageNum=1